Ns. Lamango et Cg. Charlton, Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats, PHARM BIO B, 66(4), 2000, pp. 841-849
Injection of the endogenous methyl donor, S-adenosyl methionine (SAM), into
rat brain induces Parkinson's disease (PD)-like symptoms possibly by stimu
lating deleterious protein methylation. Gel-filtration chromatography of ra
t brain extracts treated with [H-3-methyl]-SAM revealed the presence of rad
ioactive peaks with apparent molecular weights of about 5 kDa. Treatment wi
th guanidine HCl altered the elution volumes of the labeled peaks. Lyophili
zed peak fractions released volatile H-3-methanol on incubation with NaOH,
indicating the presence of carboxyl methyl esters. Because prenylated prote
ins are avid methyl accepters at the terminal carboxylic acid groups, 1 mu
mol S-farnesylcysteine (FC) analogs blocked the SAM-induced tremors in the
experimental rats. FC analogs did nut only reverse the associated rigidity,
abnormal posture, and hypokinesia, but stimulated hyperactivity in the ani
mals. This amphetamine-like effect was monitored for 20 min in an animal ac
tivity monitor and movement times between 400 +/- 100 and 560 +/- 125 s cov
ering distances between 78 +/- 29 to 125 +/- 35 m were recorded for rats tr
eated with FC analogs with or without SAM. Control animals moved only for 6
0 +/- 13 s covering about 6 +/- 1 m, indicating a 7-9-fold and 13-21-fold i
ncrease in duration of movement and distance covered, respectively. N-Acety
l-S-farnesylcysteine (AFC) potentiated amphetamine-induced ipsiversive rota
tion of 6-hydroxydopamine-lesioned rats from 390 +/- 130 to 830 +/- 110, wi
th AFC alone having no significant effect on net rotation compared to contr
ols. These data indicate that intracerebroventricular injection of SAM may
induce PD symptoms by interfering with the methylation/demethylation homeos
tasis of prenylated proteins that function in the dopaminergic and other si
gnaling pathways, and that the FC analogs may counteract the SAM effects by
acting synergistically on events subsequent to neurotransmitter release. (
C) 2000 Elsevier Science Inc.